Efparepoetin Alfa

艾帕依泊汀α

Report date: 2025/08/14 10:45:39

Base Information

Drug NameEfparepoetin Alfa
Drug Alias Name重组人促红细胞生成素-Fc融合蛋白（山东丹红制药）rhEPO-Fc (Shanhai meiye Biotech)rhEPO-Fc (Shandong Danhong Pharmaceutical)依派促红素αRecombinant human erythropoietin-Fc fusion protein (Shandong Danhong Pharmaceutical) +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShandong Danhong Pharmaceutical Co LtdSichuan Luzhou Buchang Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSichuan Luzhou Buchang Biopharmaceutical Co LtdShanghai Meiye Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A